Assessing the importance of trial characteristics as contextual factors when evaluating targeted therapies in patients with psoriatic disease: Protocol for an exploratory systematic review and meta-research project



Christine Ballegaard1,2, Tanja Schjødt Jørgensen1, Marie Skougaard1,2, Vibeke Strand3, Philip J. Mease4, Lars E. Kristensen5, Lene Dreyer2, Alice Gottlieb6, Maarten de Wit7, Robin Christensen1, Simon Tarp1